CRP and cardiovascular disorder: Interestingly, in the absence of sample collection control, the number of naturally menstruating elite athletes that were considered to be at low risk of cardiovascular disease (CRP <1 mg L−1) was double that of the number of OCP users (Larsen et al., 2020).